Operating costs and other operating income - Other Income (Details) - EUR (€) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Operating costs and other operating incomes [line item] | |||
| Grant income | € 57,000 | € 2,035,000 | € 6,618,000 |
| R&D incentives | 27,218,000 | 27,223,000 | 32,968,000 |
| Fair value Adjustment Contingent consideration Payable related to the acquisition of cellpoint | 21,760,000 | ||
| Other income | 4,458,000 | 11,515,000 | 7,686,000 |
| Total other operating income | 53,493,000 | 40,773,000 | 47,272,000 |
| National Institute For Health [member] | |||
| Operating costs and other operating incomes [line item] | |||
| Grant income | € 0 | € 0 | € 6,100,000 |